Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 13877
Country/Region: Uganda
Year: 2015
Main Partner: Children's AIDS Fund International
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $1,860,007 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $413,617
Care: Orphans and Vulnerable Children (HKID) $519,235
Care: TB/HIV (HVTB) $74,806
Care: Pediatric Care and Support (PDCS) $58,794
Testing: HIV Testing and Counseling (HVCT) $93,761
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $804
Treatment: Adult Treatment (HTXS) $659,776
Treatment: Pediatric Treatment (PDTX) $39,214
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 2,755
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 6,066
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 280
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 617
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 5,379
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 11,842
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 332
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 732
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 8,746
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 19,257
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 8,746
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 19,257
CARE_NEW Aggregated Age/sex: <15 Female 2016 59
CARE_NEW Aggregated Age/sex: <15 Male 2016 51
CARE_NEW Aggregated Age/sex: 15+ Female 2016 1,010
CARE_NEW Aggregated Age/sex: 15+ Male 2016 548
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 1,668
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 1,668
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 1,668
FN_THER Aggregated Age: <18 2016 178
FN_THER Aggregated Age: 18+ 2016 284
FN_THER Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period 2016 462
FN_THER Number of PLHIV who were nutritionally assessed and found to be clinically undernourished 2016 5,776
FN_THER Sum of Aggregated Age disaggregates 2016 462
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 1,232
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 930
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 1,254
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 9,430
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 12,690
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 6,793
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 9,144
HTS_TST By Test Result: Negative 2016 17,651
HTS_TST By Test Result: Negative 2016 23,799
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 18,385
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 24,747
HTS_TST Sum of Aggregated Age/Sex <15 2016 2,162
HTS_TST Sum of Aggregated Age/Sex <15 2016 2,913
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 16,223
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 21,834
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 18,385
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 24,747
HTS_TST Sum of Test Result disaggregates 2016 18,385
HTS_TST Sum of Test Result disaggregates 2016 24,747
HTS_TST_POS By Test Result: Positive 2016 734
HTS_TST_POS By Test Result: Positive 2016 948
OVC_ACC Number of active beneficiaries receiving support from PEPFAR OVC programs to access HIV services 2016 7,351
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2016 14,304
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 148
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 148
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 129
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 19
PMTCT_ARV Sum of New and Current disaggregates 2016 148
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2016 12
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 119
PMTCT_EID Sum of Infant Age disaggregates 2016 119
PMTCT_STAT By: Known positives at entry 2016 130
PMTCT_STAT By: Number of new positives identified 2016 18
PMTCT_STAT Number of new ANC and L&D clients 2016 1,818
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 1,729
PMTCT_STAT Sum of Positives Status disaggregates 2016 148
PP_PREV Age/sex: 10-14 Female 2016 1,499
PP_PREV Age/sex: 10-14 Male 2016 1,162
PP_PREV Age/sex: 15-19 Female 2016 3,099
PP_PREV Age/sex: 15-19 Male 2016 2,231
PP_PREV Age/sex: 20-24 Female 2016 4,576
PP_PREV Age/sex: 20-24 Male 2016 2,421
PP_PREV Age/sex: 25-49 Female 2016 6,579
PP_PREV Age/sex: 25-49 Male 2016 4,349
PP_PREV Age/sex: 50+ Female 2016 441
PP_PREV Age/sex: 50+ Male 2016 373
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2016 26,730
PP_PREV Sum of Age/Sex disaggregates 2016 26,730
PP_PREV Total number of people in the target population 2016 66,824
TB_ART Aggregated Age: <15 2016 17
TB_ART Aggregated Age: 15+ 2016 224
TB_ART Female 2016 155
TB_ART Male 2016 86
TB_ART Sum of Aggregated Age disaggregates 2016 241
TB_ART Sum of Sex disaggregates 2016 241
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2016 300
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 241
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2016 1,349
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2016 17,908
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 8,746
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 19,257
TB_SCREEN Sex: Female 2016 12,575
TB_SCREEN Sex: Male 2016 6,682
TB_SCREEN Sum of Aggregated Age disaggregates 2016 19,257
TB_SCREEN Sum of Sex disaggregates 2016 19,257
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 19,257
TX_CURR Aggregated Age/Sex: 15+ Female 2016 2,398
TX_CURR Aggregated Age/Sex: 15+ Female 2016 5,290
TX_CURR Aggregated Age/Sex: 15+ Male 2016 5,211
TX_CURR Aggregated Age/Sex: 15+ Male 2016 11,493
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 8,214
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 18,117
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 7,609
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 16,783
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 7,609
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 16,783
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2016 979
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2016 2,070
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 3,181
TX_NEW Sum of Aggregated Age/Sex disaggregates 2016 3,049
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 2,230
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 2,622
Cross Cutting Budget Categories and Known Amounts Total: $260,000
Gender: Gender Based Violence (GBV) $180,000
Post GBV Care
Collection and Use of Gender-related Strategic Information
Monitoring and Evaluation
Gender: Gender Equality $80,000
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Monitoring and Evaluation
Increase gender-equitable access to income and productive resources, including education
Collection and Use of Gender-related Strategic Information
Monitoring and Evaluation
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Monitoring and Evaluation